$GENE News

Last published 1mo ago

1mo agoMETA AMZN WMT STRP+8The next hurdle for AI agents: getting websites to let them inTechCrunch
2y agoBIVI BOXL GENEBioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVACCESS NewswireORLANDO, FL / ACCESSWIRE / October 11, 2024 / RedChip Companies will air interviews with BioVie, Inc. and Genetic Technologies Limited on the RedChip Small Stocks, Big Money™
2y agoGENEJoin Genetic Technology's Exclusive Live Investor Webinar and Q&A Session on October 2GlobeNewswireMELBOURNE, Australia, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX:GTG, NASDAQ:GENE, "Company", "GTG", or "Genetic Technologies")), a global leader in guideline-driven genomics-based tests in
2y agoGENEGenetic Technologies Invited to Join Prestigious "CancerIQ" Online Platform - Provides Access to 45 Healthcare Systems and 250 ClinicsGlobeNewswireMELBOURNE, Australia, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GENE")), a global leader in genomics-based tests in health, wellness and serious disease, is
2y agoGENEGenetic Technologies Announces Global Launch of geneType™ on Wholly Owned EasyDNA platformGlobeNewswireCHARLOTTE, N.C., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GENE")), a global leader in genomics-based tests in health, wellness and serious disease and the
2y agoGENEJoin Genetic Technology's Exclusive Live Investor Webinar and Q&A Session on August 15GlobeNewswireMELBOURNE, Australia, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX:GTG, NASDAQ:GENE, "Company", "GTG", or "Genetic Technologies")), a global leader in guideline-driven genomics-based tests in
2y agoGENEGenetic Technologies Strategic Restructure Driving USA Sales GrowthGlobeNewswireCHARLOTTE, N.C., July 26, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GENE")), a global leader in genomics-based tests in health, wellness and serious disease and the
2y agoGENEGenetic Technologies Announces Appointment of Chief Financial Officer & Company SecretaryGlobeNewswireMELBOURNE, Australia, July 16, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tests in health, wellness, and serious disease, is
2y agoGENEGeneType to Enter Canadian and New Zealand MarketsGlobeNewswireCHARLOTTE, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tests in health, wellness and serious disease and the
2y agoGENEGeneType Identifies 79.5% of People Tested are at Risk of Serious DiseaseGlobeNewswireCHARLOTTE, N.C., June 25, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tests in health, wellness and serious disease, is pleased
2y agoGENEJoin Genetic Technologies' Exclusive Live Investor Webinar and Q&A Session on June 27GlobeNewswireCHARLOTTE, N.C. and MELBOURNE, Australia, June 21, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, ASX:GTG, "Company", "GTG", or "Genetic Technologies")), a global leader in guideline-driven
2y agoGENEGenetic Technologies Expands Operational Capacity in North AmericaGlobeNewswireCHARLOTTE, N.C., June 18, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tests in health, wellness and serious disease, today
2y agoGENEGeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk TestGlobeNewswireMELBOURNE, Australia, June 05, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tests in health, wellness and serious disease, and
2y agoGENEGTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian CancerGlobeNewswireMELBOURNE, Australia, May 29, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tests in health, wellness and serious disease, is
2y agoGENEGeneType and Humanise Health host "Know Your Risk" EventGlobeNewswirePASADENA, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GeneType")), a global leader in genomics-based tests in health, wellness and serious disease, is
2y agoGENEGTG and 'Wellworks for You' sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employeesGlobeNewswireMELBOURNE, Australia, May 06, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tests in health, wellness and serious disease, is
2y agoGENEAppendix 4C & Quarterly Business Update – March 2024GlobeNewswireMELBOURNE, Australia, April 30, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX:GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in guideline-driven genomics-based testing in health, wellness and
2y agoGENEGenetic Technologies Announces Closing of US$2 Million Registered Direct OfferingGlobeNewswireMELBOURNE, Australia, April 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX:GTG, NASDAQ:GENE, "Company", "GTG", or "Genetic Technologies")), a global leader in guideline-driven genomics-based tests
2y agoGENEGenetic Technologies Announces $2 Million Registered Direct OfferingGlobeNewswireMELBOURNE, Australia, April 19, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX:GTG, NASDAQ:GENE, ", Company", , ", GTG", , or ", Genetic Technologies", )), a global leader in
2y agoGENENew Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment OutcomesGlobeNewswireMELBOURNE, Australia, April 17, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tests in health, wellness and serious disease, is
2y agoGENEGeneType Clinicians' Adoption Growing - Sales up 5-Fold Year on YearGlobeNewswireMELBOURNE, Australia, April 16, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GENE")), a global leader in genomics-based tests in health, wellness and serious disease, is
2y agoBIVI GENEGenetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TVACCESS NewswireORLANDO, FL / ACCESSWIRE / April 12, 2024 / RedChip Companies will air interviews with Genetic Technologies Limited and BioVie, Inc. on the RedChip Small Stocks, Big Money™ show, a
2y agoGENEGTG to pilot GeneType in Breast Screen centers across the U.S.GlobeNewswireMELBOURNE, Australia, April 11, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tests in health, wellness and serious disease, is
2y agoGENEEVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk"GlobeNewswireMELBOURNE, Australia, April 08, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tests in health, wellness and serious disease, is
2y agoGENEGenetic Technologies' Digital Strategy Ignites Significant Traction in US MarketGlobeNewswireMELBOURNE, Australia, April 02, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tests in health, wellness and serious disease, is
2y agoGENEGTG Global Collaborations and Innovation UpdateGlobeNewswireMELBOURNE, Australia, March 26, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tests in health, wellness and serious disease, is
2y agoGENEGENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised HealthcareGlobeNewswireMELBOURNE, Australia, March 25, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, "Company", "GENE")), a global leader in guideline-driven genomics-based testing in health, wellness and serious
2y agoGENEGTG to launch U.S. Customer Digital Media Sales CampaignGlobeNewswireMELBOURNE, Australia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, "Company", "GTG")), is pleased to announce the launch of a wide-reaching customer – targeted digital advertising
2y agoGENELaunching our most comprehensive test and expanding into new global marketsGlobeNewswireMELBOURNE, Australia, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE), is at the forefront in personalised predictive genomics, reshaping the healthcare landscape with its inventive
2y agoGENEGenetic Technologies Regains Compliance with Nasdaq Minimum Bid Price RequirementGlobeNewswireMELBOURNE, Australia, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, "Company")) a global leader in genomics-based tests in health, wellness, and serious disease, advises that it has
2y agoBIVI GENEGenetic Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TVACCESS NewswireORLANDO, FL / ACCESSWIRE / December 29, 2023 / RedChip Companies will air interviews with Genetic Technologies Limited and BioVie, Inc. on The RedChip Small Stocks Big Money® Show, a
2y agoGENEGeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized WellnessGlobeNewswireMELBOURNE, Australia, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies (GTG) is proud to provide details of a series of recent transformative initiatives. Our commitment to advancing early detection of serious
2y agoGENEGenetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio ChangeGlobeNewswireMELBOURNE, Australia, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tests in health, wellness and serious disease,
3y agoGENEGene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical TrialGlobeNewswireMELBOURNE, Australia, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX:GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in guideline-driven genomics-based testing in health, wellness and
3y agoGENEGeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and TreatmentGlobeNewswireMELBOURNE, Australia, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tests in health, wellness and serious disease, is
3y agoGENE KSCP SNGXKnightscope, Soligenix, and Genetic Technologies Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TVACCESS NewswireORLANDO, FL / ACCESSWIRE / October 6, 2023 / RedChip Companies will air interviews with Knightscope, Inc. , Soligenix, Inc. , and Genetic Technologies Limited on The
3y agoGENEGTG Signs Precision Medicine Pilot with Australia's Largest Private Hospital NetworkGlobeNewswireMELBOURNE, Australia, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")) – a global leader in genomics-based tests in health, wellness and serious disease is
3y agoGENEBreakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian ReleaseGlobeNewswireGenetic Technologies Limited ((ASX: GTG, NASDAQ:GENE) Expands Reach of Revolutionary geneType Multi-Risk Test in Australia: A major advancement towards preventative Healthcare MELBOURNE, Australia, Sept. 12, 2023
3y agoGENEGENE Positioned at the Forefront of Multi-cancer Clinical Utility Research - MRFF Grant names GTG as sole Industry PartnerGlobeNewswireMELBOURNE, Australia, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tests in health, wellness and serious disease, is
3y agoGENE SXTPGenetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report® on Bloomberg TVGlobeNewswireMELBOURNE, Australia, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in guideline driven genomics-based tests in health, wellness and
3y agoGENE SXTPGenetic Technologies Limited and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Money Report(R) on Bloomberg TVACCESS NewswireORLANDO, FL / ACCESSWIRE / September 1, 2023 / RedChip Companies will air interviews with Genetic Technologies Limited and 60 Degrees Pharmaceuticals on The RedChip Money Report®, a
3y agoGENEAnnual Results – Momentum Building on our Commercial PlansGlobeNewswireMELBOURNE, Australia, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in guideline driven genomics-based tests in health, wellness and serious
3y agoGENEGenetic Technologies Limited (GENE) Q4 2023 Earnings Call TranscriptEarnings Call Transcripts
3y agoGENEQuarterly Activities Update: Encouraging Growth for geneType Commercial Test VolumeGlobeNewswireMELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, "Company", "GTG")), a global leader in guideline-driven genomics-based testing in health, wellness and serious
3y agoGENEGenetic Technologies Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyGlobeNewswireMELBOURNE, Australia, July 21, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, "Company")) a global leader in genomics-based tests in health, wellness and serious disease, advises that it has
3y agoGENEGeneType featured on U.S. National TV to raise Breast Cancer AwarenessGlobeNewswireMELBOURNE, Australia, May 23, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")) a global leader in genomics-based tests in health, wellness and serious disease is pleased
3y agoGENENew Publication Validates geneType for Melanoma Risk AssessmentGlobeNewswireMELBOURNE, Australia, April 28, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")) a global leader in genomics-based tests in health, wellness and serious disease is
3y agoGENEQuarterly Business Update – March 2023GlobeNewswireMELBOURNE, Australia, April 27, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX:GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in guideline-driven genomics-based testing in health, wellness and
3y agoGENEPublication Validates geneType Prostate Cancer Risk TestGlobeNewswireMELBOURNE, Australia, April 19, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")) a global leader in genomics-based tests in health, wellness and serious disease is
3y agoGENEGeneType Multi-Risk Test now includes Melanoma, Pancreatic Cancer & Atrial FibrillationGlobeNewswireMELBOURNE, Australia, March 27, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")) – a global leader in genomics-based tests in health, wellness and serious disease – is